Continued trends in the conditioned place preference literature from 1992 to 1996, inclusive, with a cross-indexed bibliography

Neuroscience and Biobehavioral Reviews

Volumn 22, Issue 6, 1998, Pages 827-846

  Schechter, Martin D ^a   Calcagnetti, Daniel J ^b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b FAIRLEIGH DICKINSON UNIVERSITY   (United States)

Author keywords

Conditioned place aversion; Conditioned place preference; Drug effects; Pavlovian conditioning; Place approach; Review

Indexed keywords

AVERSION; BEHAVIOR; CONDITIONING; CONFERENCE PAPER; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PUBLICATION;

ANIMALS; CHOICE BEHAVIOR; CONDITIONING, CLASSICAL; CONDITIONING, OPERANT; PSYCHOLOGY, EXPERIMENTAL;

EID: 0031759069     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(98)00012-8     Document Type: Conference Paper

References (312)

1. Agmo A., Federman I., Navarro V., Padua M., Velazquez G. Reward and reinforcement produced by drinking water: role of opioids and dopamine receptor subtypes. Pharmacol. Biochem. Behav. 46:1993;183-194.
2. Agmo A., Galvan A., Talamantes B. Reward and reinforcement produced by drinking sucrose: two processes than may depend on different neurotransmitters. Pharmacol. Biochem. Behav. 52:1995;403-414.
3. Agmo A., Gomez M. Sexual reinforcement is blocked by infusion of naloxone into the medial preoptic area. Behav. Neurosci. 107:1993;812-818.
4. Agmo A., Gomez M., lrazabal Y. Enkephalinase inhibition facilitates sexual behavior in the male rat but does not produce conditioned place preference. Pharmacol. Biochem. Behav. 47:1994;771-778.
5. Agmo A., Rojas J., Vazquez P. Inhibitory effect of opiates on male rat sexual behavior may be mediated by opiate receptors outside the central nervous system. Psychopharmacology. 107:1992;89-96.
6. Alexander G. M., Packard M. G., Hines M. Testosterone has rewarding affective properties in male rats: implications for the biological basis of sexual motivation. Behav. Neurosci. 108:1994;424-428.
7. Baker D. A., Khroyan T. V., O'Dell L. E., Fuchs R. A., Neiswander J. L. Differential effects of intra-accumbens sulpride on cocaine-induced locomotion and conditioned place preference. J. Pharmacol. Exp. Ther. 279:1996;392-401.
8. *Baker, D.A.; O'Dell, L.E.; Khroyan, T.V.; Neiswander, J.L., Differential effects of intra-accumbens sulpride oncocaine-induced locomotion and conditioned place preference. Soc. Neurosci. 22:1630, Abstr.; 1994.
9. *Baker, D.A.; Specio, S.E.; Tran-Nguyen, L.T.L.; Archer, T.L.; Neisewander, J.L., Amphetamine infusions into the ventrolateral striatum produce conditioned place preference. Soc. Neurosci. 22:707, Abstr.; 1996.
10. Bals-Kubik R., Ableitner A., Herz A., Shippenberg T. S. Neuroanatomical sites mediating the motivational effects of opioids as mapped by the conditioned place preference paradigm in rats. J. Pharmacol. Exp. Ther. 264:1993;489-495.
11. Bardo M. T., Bowling S. L., Robinet P. M., Rowlett J. K., Lacy M., Mattingly B. A. Role of dopamine Dl and D2 receptors in novelty-maintained place preference. Exp. Clin. Psychopharmacol. 1:1993;101-109.
12. Bardo M. T., Bowling S. L., Rowlett J. K., Manderscheid P., Buxton S. T., Dwoskin L. P. Environmental enrichment attenuates locomotor sensitization, but not in vitro dopamine release, induced by amphetamine. Pharmacol. Biochem. Behav. 51:1995;397-405.
13. •Bardo, M.T.; Rowlett, J.K.; Harris, M.J., Conditioned place preference using opiate and stimulant drugs: a meta-analysis. Neurosci. Biobehav. Rev. 1:39-51; 1995.
14. Barr G. A., Rossi G. Conditioned place preference from ventral tegmental injection of morphine in neonatal rats. Dev. Brain Res. 66:1992;133-136.
15. Barr G. A., Wang S. Peripheral and central administration of cocaine produce conditioned odor preferences in the infant rat. Brain Res. 599:1992;181-185.
16. Baumeister A. A., Hurry M., Curtis W., Chaney T. M., Wolf E., Leoni R. R. The antinociceptive and motivational effects of intranigral injection of opioid agonists. Neuropharmacology. 32:1993;1299-1303.
17. Bechara A., Harrington F., Nader K., van der Kooy D. Neurobiology of motivation: double dissociation of two motivational mechanisms mediating opiate reward in drug-naive versus drug-dependent animals. Behav. Neurosci. 106:1992;798-807.
18. Bechara A., Martin G. M., Pridgar A., van der Kooy D. The parabrachial nucleus: a brain stem substrate critical for mediating the aversive motivational effects of morphine. Behav. Neurosci. 107:1993;147-160.
19. Bechara A., van der Kooy D. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not deprived rats. Behav. Neurosci. 106:1992;351-363.
20. Bechara A., van der Kooy D. Chronic exposure to morphine does not alter the neural tissues subserving its acute rewarding properties: apparent tolerance is overshadowing. Behav. Neurosci. 106:1992;364-373.
21. *Beninger, R.J.; Nakenechny, P.L.; Todd, M.J., Inhibition of protein kinase A in the nucleus accumbens blocks amphetamine-produced conditioned place preference in rats. Soc. Neurosci. 22:1127, Abstr; 1996.
22. Bespalov A. The expression of both amphetamine-conditioned place preference and pentylenetetrazol-conditioned aversion is attenuated by the NMDA receptor antagonist (±)-CPP. Drug Alcohol Depend. 41:1996;85-88.
23. Bespalov A., Dumpis M., Piotrovsky L., Zvartau E. Excitatory amino acid receptor antagonist kynurenic acid attenuates rewarding potential of morphine. Eur. J. Pharmacol. 264:1994;233-239.
24. Bienkowski P., Kuca P., Kostowski W. Conditioned place preference after prolonged pre-exposure to ethanol. Pol. J. Pharmacol. 47:1995;189-191.
25. Bienkowski P., Kuca P., Piasecki J., Kostowski W. Low dose of ethanol induces conditioned place preference in rats after repeated exposures to ethanol or saline injections. Alcohol Alcohol. 31:1996;547-553.
26. Bilsky E. J., Montegut M. J., Delong C. L., Reid L. D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;PL85-PL90.
27. Bisaga A., Sikora J., Kostowski W. The effect of drugs interacting with serotonergic 5HT3 and 5HT4 receptors on morphine place conditioning. Polish J. Pharmacol. 45:1993;513-519.
28. *Blakley, G.G.; Lewis, M.J. Latency of conditioning trials and extent of chronic conditioning effect ETOH-induced conditioned place preference and aversion. Soc. Neurosci. 20:1610, Abstr.; 1994.
29. Boix F., Sandor P., Nogueira P. J., Huston J. P., Schwarting R. K. Relationship between dopamine release in nucleus accumbens and place preference induced by substance P injected into the nucleus basalis magnocellularis region. Neuroscience. 64:1995;1045-1055.
30. Bolanos C. A., Garmsen G. M., Clair M. A., McDougall S. A. Effects of the kappa-opioid receptor agonist U-50,488 on morphine-induced place preference conditioning in the developing rat. Eur. J. Pharmacol. 317:1996;1-8.
31. Borisova E. V., Sudakov S. K. The modulating effect of the thyrotropin-releasing hormone on genetically induced mechanisms of morphine sensitivity. Zh. Vyssh. Nerv. Deiat. Im. I.P. Pavlova. 45:1995;1174-1181.
32. Borlongan C. V., Watanabe S. Failure to discriminate conspecifics in amygdaloid-lesioned mice. Pharmacol. Biochem. Behav. 48:1994;677-680.
33. Borsini F., Brambilla A., Cesana R., Donetti A. The effect of DAU 6215, a novel 5HT-3 antagonist, in animal models of anxiety. Pharmacol. Res. 27:1993;151-164.
34. *Borszcz, G.S.; Johnson, C.P., Morphine-induced analgesia, abstinence, reward and aversion in the fawn hooded rat. Soc. Neurosci. 19:1025, Abstr.; 1993.
35. Bowling S. L., Bardo M. T. Locomotor and rewarding effects of amphetamine in enriched, social, and isolate reared rats. Pharmacol. Biochem. Behav. 48:1994;459-464.
36. *Braida, D.; Sala, M.; Calcaterra, P.; Leone, M.P.; Gori, E., Comparison (sic) morphine and etonitazene in rat conditioned place preference (CPP) test. Pharmacol. Res. 25(2):329; 1992.
37. *Bridger, W.H.; Yadin, E., Effects of interstimulus interval (ISI) on cocaine place preference conditioning. Soc. Neurosci. 18:1571, Abstr; 1992.
38. Brockwell N. The differential role of Al and A2 adenosine receptor subtypes in locomotor activity and place conditioning in rats. Behav. Pharmacol. 7:1996;373-383.
39. Brockwell N. A computerized system for the simultaneous monitoring of place conditioning and locomotor activity in rats. J. Neurosci. Methods. 64:1996;227-232.
40. Brown E. E., Fibiger H. C. Differential effects of excitotoxic lesions of the amygdala on cocaine-induced locomotion and conditioned place preference. Psychopharmacology. 113:1993;123-130.
41. Cabib S., Puglisi-Allegra S., Genua C., Simon H., Le Moal M., Piazza P. V. Dose-dependent aversive and rewarding effects of amphetamine as revealed by a new place conditioning apparatus. Psychopharmacology. 125:1996;92-96.
42. Cador M., Ahmed S. H., Koob G. F., Le Moal M., Stinus L. Corticotropin-releasing factor induces a place aversion independent of its neuroendocrine role. Brain Res. 597:1992;304-309.
43. •Calcagnetti, D.J.; Keck, B.J.; Quatrella, L.A.; Schechter, M.D., Blockade of cocaine-induced conditioned place preference: relevance to cocaine abuse therapeutics. Life Sci. 56:475-483; 1995.
44. *Calcagnetti, D.J.; Quatrella, L.A.; Calcagnetti, R.L.; Magistro, P.J.; Adest, J.C., Centrally administered cocaethylene produces a conditioned place preference in rats that is blocked by naltrindole. Eastern Psych. Assoc. 67:2, Abstr; 1996.
45. Calcagnetti D. J., Quatrella L. A., Schechter M. D. Olfactory bulbectomy disrupts the expression of cocaine-induced conditioned place preference. Physiol. Behav. 59:1996;597-604.
46. Calcagnetti D. J., Schechter M. D. Reducing the time needed to conduct conditioned place preference testing. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16:1992;969-976.
47. Calcagnetti D. J., Schechter M. D. Place conditioning reveals the rewarding aspect of social interaction in juvenile rats. Physiol. Behav. 51:1992;667-672.
48. Calcagnetti D. J., Schechter M. D. Attenuation of drinking sweetened water following calcium channel blockade. Brain Res. Bull. 28:1992;967-973.
49. Calcagnetti D. J., Schechter M. D. Place preference for the psychostimulant cathinone is blocked by pretreatment with a dopamine release inhibitor. Prog. Neuropsychopharmacol. Biol. Psychiatry. 17:1993;637-649.
50. Calcagnetti D. J., Schechter M. D. Extinction of cocaine-induced place approach in rats: a validation of the "biased" conditioning procedure. Brain Res. Bull. 30:1993;695-700.
51. Calcagnetti D. J., Schechter M. D. Isradipine produces neither a conditioned place preference nor aversion. Life Sci. 54:1994;PL81-PL86.
52. Calcagnetti D. J., Schechter M. D. Nicotine place preference using the biased method of conditioning. Prog. Neuropsychopharmacol. Biol. Psychiat. 18:1994;925-933.
53. *Cervo, L.; Mukherjee, S.; Bertaglia, A.; Consolo, S.; Samanin, R., Role of protein kinase C on the acquistion and expression of cocaine conditioning place preference in rats. Soc. Neurosci. 22:935, Abstr; 1996.
54. Cervo L., Rossi C., Samanin R. Clonidine-induced place preference is mediated by alpha 2-adrenoceptors outside the locus coeruleus. Eur. J. Pharmacol. 283:1993;201-207.
55. Cervo L., Pozzi L., Samanin R. 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats. Pharmacol. Biochem. Behav. 55:1996;33-37.
56. Cervo L., Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res. 673:1995;242-250.
57. *Clavier, M.C.; Nores, W.L.; Olson, R.D.; Vaccarino, A.L., NMDA antagonist, MK-801, antagonizes the development of morphine-induced conditioned place preference. Soc. Neurosci. 22:174, Abstr; 1996.
58. Corcoran M. E., Lanius R., Duren A. Reinforcing and punishing consequences of kindling. Epilepsy Res. 13:1992;179-186.
59. •Crabbe, J.C.; Phillips, T.J.; Cunningham, C.L.; Belknap, J.K., Genetic determinants of ethanol reinforcement. Ann. NY Acad. Sci. 654:302-310; 1992.
60. Crawford C. A., McDougall S. A., Bolanos C. A., Hall S., Berger S. P. The effects of the kappa agonist U-50, 488 on cocaine-induced conditioned and unconditioned behaviors and Fos immunoreactivity. Psychopharmacology. 120:1995;392-399.
61. Crowder W. F., Hutto C. W. Jr. Operant place conditioning measures examined using two nondrug reinforcers. Pharmacol. Biochem. Behav. 41:1992;817-824.
62. Crowder W. F., Hutto C. W. Jr. Operant place conditioning measures examined using morphine reinforcement. Pharmacol. Biochem. Behav. 41:1992;825-835.
63. Cunningham C. L. Localization of genes influencing ethanol-induced conditioned place preference and locomotor activity in BXD recombinant inbred mice. Psychopharmacology. 120:1995;28-41.
64. •Cunningham, C.L., Pavlovian drug conditioning. In: Haaren, F., ed., Methods in Behavioral Pharmacology. Amsterdam: Elsevier; 1993:349-381.
65. Cunningham C. L., Malott D. H., Dickinson S. D., Risinger F. O. Haloperidol does not alter expression of ethanol-induced conditioned place preference. Behav. Brain Res. 50:1992;1-5.
66. *Cunningham, C.L.; Malott, D.H.; Risinger, F.O., Antagonism of ethanol-induced conditioned place preference by theophylline. Soc. Neurosci. 18:1074, Abstr; 1992.
67. Cunningham C. L., Niehus J. S. Drug-induced hypothermia and conditioned place aversion. Behav. Neurosci. 107:1993;468-479.
68. Cunningham C. L., Niehus D. R., Malott D. H., Prather L. K. Genetic differences in the rewarding and activating effects of morphine and ethanol. Psychopharmacology. 107:1992;385-393.
69. Cunningham C. L., Niehus J. S., Noble D. Species difference in sensitivity to ethanol's hedonic effects. Alcohol. 10:1993;97-102.
70. Cunningham C. L., Noble D. Conditioned activation induced by ethanol: role in sensitization and conditioned place preference. Pharmacol. Biochem. Behav. 43:1992;307-313.
71. Cunningham C. L., Noble D. Methamphetamine-induced conditioned place preference or aversion depending upon dose and presence of drug. Ann. NY Acad. Sci. 654:1992;431-433.
72. Cunningham C. L., Prather L. K. Conditioning trial duration affects ethanol-induced conditioned place preference in mice. Anim. Learn. Behav. 20:1992;l87-194.
73. *Damianopoulos, E.N.; Carey, R.J., Effects of repeated caffeine treatment on hyperlocomotion and conditioned place preference. Soc. Neurosci. 18:867, Abstr; 1992.
74. D'Aquila P. S., Garau B., Gessa G. L., Serra G. MK-801 inhibits morphine conditioned place preference. Pharmacol. Res. 26:1992;31-35.
75. Davies A. M., Parker L. A. Fenfluramine-induced place aversion in a three-choice apparatus. Pharmacol. Biochem. Behav. 44:1993;595-600.
76. DeBeun R., Jansen E., Geerts N. E., Slangen J. L., Van de Poll N. E. Temporal characteristics of appetitive stimulus effects of luteinizing hormone-releasing hormone in male rats. Pharmacol. Biochem. Behav. 42:1992;445-450.
77. DeBeun R., Jansen E., Slangen J. L., Van de Poll N. E. Testosterone as appetitive and discriminative stimulus in rats, sex- and dose-dependent effects. Physiol. Behav. 52:1992;629-634.
78. DeBeun R., Lohmann A., DeVry J. Conditioned taste aversion and place preference induced by the calcium channel agonist nimodipine in rats. Pharmacol. Biochem. Behav. 54:1996;657-663.
79. DeFonseca F. R., Rubio P., Martin-Calderon J. L., Caine S. B., Koob G. F., Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur. J. Pharmacol. 274:1995;47-55.
80. Dell'Omo G., Fiore M., Petruzzi S., Alleva E., Bignami G. Neurobehavioral development of CD-1 mice after combined gestational and postnatal exposure to ozone. Arch. Toxicol. 69:1995;608-616.
81. Dell'Omo G., Laviola G., Chiarotti F., Alleva E., Bignami G. Prenatal oxazepam effects on cocaine conditioned place preference in developing mice. Neurotoxicol. Teratol. 15:1993;207-210.
82. DelPozo E., Barrios M., Baeyens J. M. The NMDA receptor antagonist dizocilpine (MK-801) stereoselectively inhibits morphine-induced place preference conditioning in mice. Psychopharmacology. 125:1996;209-213.
83. Devine D. P., Reinscheid R. K., Monsma F. J. Jr., Civelli O., Akil H. The novel neuropeptide orphanin FQ fails to produce conditioned place preference or aversion. Brain Res. 727:1996;225-229.
84. deVries T. J., Babovic-Vuksanovic D., Elmer G., Shippenberg T. S. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology. 120:1995;442-448.
85. *Dickinson, S.D.; Cunningham, C.L., The effect of naltrindole on the expression of ethanol-induced conditioned place preference. Soc. Neurosci. 20:1608, Abstr; 1994.
86. Di Scala G., Oberling P., Rocha B., Sandner G. Conditioned place preference induced by RO 16-6028, a benzodiazepine receptor partial agonist. Pharmacol. Biochem. Behav. 41:1992;859-862.
87. Durazzo T. C., Gauvin D. V., Goulden K. L., Briscoe R. J., Holloway F. A. Cocaine-induced conditioned place approach in rats: the role of dose and route of administration. Pharmacol. Biochem. Behav. 49:1994;1001-1005.
88. Duvauchelle C. L., Levitin M., MacConell L. A., Lee L. K., Ettenberg A. Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward. Brain Res. 576:1992;104-110.
89. Duvauchelle C. L., MacConell L. A., Eremia A. D., Ettenberg A. Pimozide prevents the development of conditioned place preferences induced by rewarding locus coeruleus stimulation. Behav. Brain Res. 50:1992;85-92.
90. *El-Awady, E.; Wilson, M.C., Place conditioning effects of cocaine and etinitazene in food-deprived rats. Pharmacologist 34:207; 1992.
91. *Essman, W.D.; Lucki, I., Reinforcing effects of d-amphetamine and morphine demonstrated using an instrumental-approach place preference conditioning procedure. Soc. Neurosci. 22:706, Abstr; 1996.
92. Ferger B., Stahl D., Kuschinsky K. Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena? Naunyn Schmiedebergs Arch. Pharmacol. 353:1996;545-551.
93. Fleming A. S., Korsmit M., Deller M. Rat pups are potent reinforcers to the maternal animal: effects of experience, parity, hormones, and dopamine function. Psychobiology. 22:1994;44-53.
94. Fletcher P. J., Ming Z.-H., Higgins G. A. Conditioned place preference induced by microinjection of 8-OH-DPAT into the dorsal or medial raphé nucleus. Psychopharmacology. 113:1993;31-36.
95. Fletcher P. J., Tampakeras M., Yeomans J. S. Median raphé injections of 8-OH-DPAT lower frequency thresholds for lateral hypothalamic self-stimulation. Pharmacol. Biochem. Behav. 52:1995;65-71.
96. Frisch C., Hasenöhri R. U., Mattern C. M., Häcker R., Huston J. P. Blockade of lithium chloride-induced conditioned place aversion as a test for antiemetic agents: comparison of metoclopramide with combined extracts of Zingiber officinale and Ginkgo biloba. Pharmacol. Biochem. Behav. 52:1995;321-327.
97. Funda M., Suzuki T., Narita M., Misawa M., Nagase H. Blockade of morphine reward through the activation of kappa-opioid receptors in mice. Neuropharmacology. 32:1993;1315-1323.
98. Gatley S. J., Meehan S. M., Chen R., Pan D.-F., Schechter M. D., Dewey S. L. Place preference and microdialysis studies with two derivatives of methylphenidate. Life Sci. 58:1996;PL345-PL352.
99. Gauvin D. V., Briscoe R. J., Goulden K. L., Holloway F. A. Aversive attributes of ethanol can be attenuated by dyadic social interaction in the rat. Alcohol. 11:1994;247-251.
100. •Gauvin, D.V.; Holloway, F.A., Historical factors in the development of ETOH-conditioned place preference. Alcohol 9:1-7; 1992.
101. Gerhardt P., Hasenöhrl R. U., Hock F. J., Huston J. P. Mnemogenic effects of injecting RA-octil, a CE-inhibitor derivate, systemically or into the basal forebrain. Psychopharmacology. 111:1993;442-448.
102. Gerhardt P., Voits M., Fink H., Huston J. P. Evidence for mnemotropic action of cholecystokinin fragments Boc-CCK-4 and CCK-8S. Peptides. 15:1994;689-697.
103. Gerrits M. A., Patkina N., Zvartau E. E., van Ree J. M. Opioid blockade attenuates acquisition and expression of cocaine-induced place preference conditioning in rats. Psychopharmacology. 119:1995;92-98.
104. *Goldstein, K.R.; Knapp, D.J.; Saiff, E.I.; Pohorecky, L.A.; Benjamin, D., Sensitization to ethanol demonstrated in place-preference and locomotor activation. Soc. Neurosci., 18:107, Abstr; 1992.
105. *Gong, W.; Neill, D.B.; Justice, J.B., Jr., Locomotor activating and rewarding effects of dopaminergic agonists in ventral pallidum of rats. Soc. Neurosci. 20:1627, Abstr; 1994.
106. Gong W., Neill D. B., Justice J. B. Jr. Increased sensitivity to cocaine place-preference conditioning by septal lesions in rats. Brain Res. 683:1995;221-227.
107. Gong W.et al. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res. 707:1996;64-74.
108. *Gong, W.; Neill, D.B.; Justice, J.B., Jr., Locomotor response to novelty does not predict cocaine place preference conditioning in rats. Soc. Neurosci. 19:1347, Abstr; 1993.
109. Gong W., Neill D. B., Justice J. B. Jr. Locomotor response to novelty does not predict cocaine place preference conditioning in rats. Pharmacol. Biochem. Behav. 53:1996;191-196.
110. Guyon A., Assouly-Besse F., Biala G., Puech A. J., Thiebot M.-H. Potentiation by low doses of selected neuroleptics of food-induced conditioned place preference in rats. Psychopharmacology. 110:1993;460-466.
111. Harris G. C., Aston-Jones G. Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology. 9:1993;303-311.
112. Hasenöhrl R. U., Frisch C., Junghans U., Muller H. W., Huston J. P. Facilitation of learning following injection of the chondroitin sulfate proteoglycan biglycan into the vicinity of the nucleus basalis magnocellularis. Behav. Brain Res. 70:1995;59-67.
113. Hemby S. E., Jones G. H., Hubert G. W., Neill D. B., Justice J. B. Jr. Assessment of the relative contribution of peripheral and central components in cocaine place conditioning. Pharmacol. Biochem. Behav. 47:1994;973-979.
114. Hemby S. E., Jones G. H., Justice J. B. Jr., Neill D. B. Conditioned locomotor activity but not conditioned place preference following intra-accumbens infusions of cocaine. Psychopharmacology. 106:1992;330-336.
115. Hemby S. E., Jones G. H., Neill D. B., Justice J. B. Jr. 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence cocaine-induced place conditioning. Behav. Brain Res. 49:1992;225-230.
116. Herz, A., Receptor-selective bi-directional modulation of reward mechanisms by opioids. In: Harris, L., ed., Problems of Drug Dependence 1992, Vol. 132. NIDA Res. Monograph. Rockville, MD: NIDA; 1993:423-424.
117. Heyser C. J., Goodwin G. A., Moody C. A., Spear L. P. Prenatal cocaine exposure attenuates cocaine-induced odor preference in infant rats. Pharmacol. Biochem. Behav. 42:1992;169-173.
118. Heyser C. J., Miller J. S., Spear N. E., Spear L. P. Prenatal exposure to cocaine disrupts cocaine-induced conditioned place preference in rats. Neurotoxicol. Teratol. 14:1992;57-64.
119. Higgins G. A., Joharchi N., Sellers E. M. Behavioral effects of the 5-hydroxytryptamine3 receptor agonists 1-phenylbiguanide and m-chlorophenylbiguanide in rats. J. Pharmacol. Exp. Ther. 264:1993;1440-1449.
120. Higgins G. A., Nguyen P., Joharchi N., Sellers E. M. Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal. Psychopharmacology. 105:1992;322-328.
121. Higgins G. A., Nguyen P., Sellers E. M. The NMDA antagonist dizocilpine (MK801) attenuates motivational as well as somatic aspects of naloxone precipitated opioid withdrawal. Life Sci. 50:1992;PL167-PL172.
122. Higgins G. A., Nguyen P., Sellers E. M. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists [published erratum appears in Brain Res., 1992, 581, 359]. Brain Res. 572:1992;208-215.
123. Hinson R. E., McKee S. A., Lovenjak T., Wall A.-M. The effect of CS-US interval and extinction on place conditioning and analgesic tolerance with morphine. J. Psychopharmacol. 7:1993;164-172.
124. Hiroi N., White N. M. The ventral pallidum area is involved in the acqusition but not expression of the amphetamine conditioned place preference. Neurosci. Lett. 156:1993;9-12.
125. Hoffman D. C. The noncompetitive NMDA antagonist MK-801 fails to block amphetamine-induced place conditioning in rats. Pharmacol. Biochem. Behav. 47:1994;907-912.
126. *Hoffman, D.C.; Donovan, H., The noncompetitive NMDA antagonist MK-801 fails to block the rewarding or locomotor-activating effects of amphetamine in rats. Soc. Neurosci. 18:1575, Abstr; 1992.
127. Holloway F. A., King D. A., Bedingfield J. B., Gauvin D. V. Role of context in ethanol tolerance and subsequent hedonic effects. Alcohol. 9:1992;109-116.
128. Joharchi N., Sellers E. M., Higgins G. A. Effect of 5-HT3 receptor antagonists on the discriminative stimulus properties of morphine in rats. Psychopharmacology. 112:1993;111-115.
129. *Jones, E.A.; Williams, H.L.; Myers, R.D.; McMillen, B.A., Neurotransmitter release in the mesolimbic system of rats trained in the conditioned place preference paradigm with cocaine. Soc. Neurosci. 22:992, Abstr; 1996.
130. Josselyn S. A., Beninger R. J. Neuropeptide Y: intraaccumbens injections produce a place preference that is blocked by cis-flupenthixol. Pharmacol. Biochem. Behav. 46:1993;543-552.
131. *Kaddis, F.G.; Layer, R.T.; Uretsky, N.J.; Wallace, L.J., AMPA/kainate receptors in the nucleus accumbens are involved in mediating conditioned place preference elicited by amphetamine, cocaine, and morphine. Soc. Neurosci. 18:1576, Abstr; 1992.
132. Kaddis F. G., Uretsky N. J., Wallace L. J. DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference. Brain Res. 697:1995;76-82.
133. *Keating, G.L.; Winn, P., Excitotoxic lesions of the pedunculopontine and laterodorsal tegmental nuclei in rats: II. Effects on conditioned place preference. Soc. Neurosci. 22:444, Abstr; 1996.
134. Khroyan T. V., Baker D. A., Neisewander J. L. Dose-dependent effects of the D3-preferring agonist 7-OH-DPAT on motor behaviors and place conditioning. Psychopharmacology. 122:1995;351-357.
135. Kim H. S., Jang C. G., Oh K. W., Seong Y. H., Rheu H. M., Cho D. H., Karg S. Y. Effects of ginseng total saponin on cocaine-induced hyperactivity and conditioned place preference in mice. Pharmacol. Biochem. Behav. 53:1996;185-190.
136. Kim H. S., Jang C. G., Park W. K. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice. Pharmacol. Biochem. Behav. 55:1996;11-17.
137. Kim H. S., Jang C. G., Park W. K., Oh K. W., Rheu H. M., Cho D. H., Oh S. Blockade by ginseng total saponin of methamphetamine-induced hyperactivity and conditioned place preference in mice. Gen. Pharmacol. 27:1996;199-204.
138. Kim H. S., Park W. K. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J. Pharmacol. Exp. Ther. 275:1995;551-557.
139. Kim H. S., Park W. K., Jang C. G., Oh S. Inhibition by MK-801 of cocaine-induced sensitization, conditioned place preference, and dopamine-receptor supersensitivity in mice. Brain Res. Bull. 40:1996;201-207.
140. Kivastik T., Rutkauskaite J., Zharkovsky A. Nitric oxide synthesis inhibition attenuates morphine-induced place preference. Pharmacol. Biochem. Behav. 53:1996;1013-1015.
141. Kivastik T., Vuorikallas K., Piepponen T. P. Morphine- and cocaine-induced conditioned place preference: effects of quinpirole and preclamol. Pharmacol. Biochem. Behav. 54:1996;371-375.
142. *Klebaur, J.E.; Miller, D.; Bardo, M.T., The effect of anxiolytics on novelty-induced place preference. Soc. Neurosci. 20:1606, Abstr; 1994.
143. Kling-Petersen T., Ljung E., Wollter L., Svensson K. Effects of dopamine D3 preferring compounds on conditioned place preference and intracranial self-stimulation in the rat. J. Neural Trans. Gen. Sect. 101:1995;27-39.
144. Kosten T. A. Clonidine attenuates conditioned place aversion produced by naloxone-precipitated opiate withdrawal. Eur. J. Pharmacol. 254:1994;59-63.
145. Kosten, T.A.; Marby, D.W.; Nestler, E.J., Chronic buprenorphine attenuates cocaine place preference. In: Harris, L., ed. Problems of Drug Dependence 1991, Vol. 119, NIDA Res. Monograph. Rockville, MD: NIDA; 1992:348.
146. Kosten T. A., Miserendino M. J., Chi S., Nestler E. J. Fischer and Lewis rat strains show differential cocaine effects in conditioned place preference and behavioral sensitization but not in locomotor activity or conditioned taste aversion. J. Pharmacol. Exp. Ther. 269:1994;137-144.
147. Kosten T. A., Nestler E. J. Clozapine attenuates cocaine conditioned place preference. Life Sci. 55:1994;PL9-PL14.
148. •Krauth, J., Parametric analysis of sojourn times in conditioned place preference experiments. J. Neurosci. Methods 42:219-227; 1992.
149. Kuzmin A., Patkina N., Pchelintsev M., Zvartau E. Isradipine is able to separate morphine-induced analgesia and place conditioning. Brain Res. 593:1992;221-225.
150. Kuzmin A. V., Zvartau E. E. The reinforcing properties of psychostimulating preparations on models of conditioned-reflex place preference in mice. Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova. 45:1995;802-810.
151. Laviola G., Dell'Omo G., Alleva E., Bignami G. Ontogeny of cocaine hyperactivity and conditioned place preference in mice. Psychopharmacology. 107:1992;221-228.
152. Laviola G., Dell'Omo G., Chiarotti F., Bignami G. D-amphetamine conditioned place preference in developing mice: relations with changes in activity and stereotypies. Behav. Neurosci. 108:1994;514-524.
153. Layer R. T., Kaddis F. G., Wallace L. J. The NMDA receptor antagonist MK-801 elicits conditioned place preference in rats. Pharmacol. Biochem. Behav. 44:1993;245-247.
154. Layer R. T., Uretsky N. J., Wallace L. J. Effects of the AMPA/kainate receptor antagonist DNQX in the nucleus accumbens on drug-induced conditioned place preference. Brain Res. 617:1993;267-273.
155. Lebedev A. A., Shabanov P. D. A comparison of the self-stimulation reaction and of conditioned place preference with fenamine administration in rats. Zh. Vyssh. Nerv. Deiat. Im. I. P. Pavlova. 42:1992;692-698.
156. Le Pen G., Duterte-Boucher D., Costentin J. Place conditioning with cocaine and the dopamine uptake inhibitor GBR12783. Neuroreport. 7:1996;2839-2842.
157. Lepore M., Franklin K. B. N-methyl-D-aspartate lesions of the pedunculopontine nucleus block acquisition and impair maintenance of responding reinforced with brain stimulation. Neuroscience. 71:1996;147-155.
158. Lepore M., Vorel S. R., Lowinson J., Gardner E. L. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci. 56:1995;2073-2080.
159. Lett B. T. Pairings of a drug or place conditioned stimulus with lithium chloride produce conditioned sickness, not antisickness. Behav. Neurosci. 106:1992;106-111.
160. *Luxton, T.L.; Parker, L.A.; Siegel, S., Effect of ibogaine on morphine and naloxone-induced place conditioning. Soc. Neurosci. 20:1230, Abstr; 1994.
161. Luxton T., Parker L. A., Siegel S. lbogaine fails to interrupt the expression of a previously established one-trial morphine place preference. Prog. Neuropsychopharmacol. Biol. Psychiatry. 20:1996;857-872.
162. *Mallet, P.E.; Beninger, R.J., 7-OH-DPAT produces place conditioning in a dose-dependent manner in rats. Soc. Neurosci. 20:153, Abstr; 1994.
163. *Mallet, P.E.; Beninger, R.J., Injections of delta-9-THC, but not anandamide, produce a conditioned place aversion in Wistar rats. Soc. Neurosci. 22:1131, Abstr; 1996.
164. Mamoon A. M., Barnes A. M., Ho I. K., Hoskins B. Comparative rewarding properties of morphine and butorphanol. Brain Res. Bull. 38:1995;507-511.
165. *Mamoon, A.M.; Ho, I.K.; Hoskins, B., Studies comparing reinforcing properties of butorphanol (stadol) and morphine. Pharmacologist 35:189; 1993.
166. Marona-Lewicka D., Rhee G. S., Sprague J. E., Nichols D. E. Reinforcing effects of certain serotonin-releasing amphetamine derivatives. Pharmacol. Biochem. Behav. 53:1996;99-105.
167. *Marona-Lewicka, D.; Sprague, J.E.; Nichols, D.E., Conditioned place preference effect of 5-methoxy-6-methyl 2-aminoindan (MMAI): a comparison study with entactogens and fenfluramine. Soc. Neurosci. 20:379, Abstr; 1994.
168. *Marroquin, E.; Agmo, A., Reward and reinforcement differentiated. Soc. Neurosci. 18:711, Abstr; 1992.
169. Martinez M., Guillen-Salazar F., Salvador A., Simon V. M. Successful intermale aggression and conditioned place preference in mice. Physiol. Behav. 58:1995;323-328.
170. *Masukawa, Y.; Suzuki, T.; Misawa, M., Enhancing effects of opioids and antihistamines on psychostimulants-induced place preference in rats. Jpn. J. Psychopharmacol. 58:410; 1992.
171. Masukawa Y., Suzuki T., Misawa M. Differential modification of the rewarding effects of methamphetamine and cocaine by opioids and antihistamines. Psychopharmacology. 111:1993;139-143.
172. Mayer L. A., Parker L. A. Rewarding and aversive properties of IP and SC cocaine: assessment by place and taste conditioning. Psychopharmacology. 112:1993;189-194.
173. McAlonan G. M., Robbins T. W., Everitt B. J. Effects of medial dorsal thalamic and ventral pallidal lesions on the acqusition of a conditioned place preference: further evidence for the involvement of the ventral striatopallidal system in reward-related processes. Neuroscience. 52:1993;605-620.
174. McGregor I. S., Issakidis C. N., Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol. Biochem. Behav. 53:1996;657-664.
175. McKee S. A., Hinson R. E., Baxter B. W. A context-specific detrimental effect of UCS preexposure on place conditioning with morphine. Anim. Learn. Behav. 22:1994;282-290.
176. Meehan S. M., Schechter M. D. Conditioned place preference/aversion to fenfluramine in Fawn Hooded and Sprague-Dawley rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 18:1994;575-584.
177. Meisel R. L., Joppa M. A. Conditioned place preference in female hamsters following aggressive or sexual encounters. Physiol. Behav. 56:1994;1115-1118.
178. Meisel R. L., Joppa M. A., Rowe R. K. Dopamine receptor antagonists attenuate conditioned place preference following sexual behavior in female Syrian hamsters. Eur. J. Pharmacol. 309:1996;21-24.
179. Menkens K., Bilsky E. J., Wild K. D., Portoghese P. S., Reid L. D., Porreca F. Cocaine place preference is blocked by the delta-opioid receptor antagonist, naltrindole. Eur. J. Pharmacol. 219:1992;345-346.
180. *Menzaghi, F.; Schulteis, G.; Koob, G.F.; Stinus, L.; Heinrichs, S.C., Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Soc. Neurosci. 20:1068, Abstr; 1994.
181. Miner L. L., Drago J., Chamberlin P. M., Donovan D., Uhl G. R. Retained cocaine conditioned place preference in D1 receptor deficient mice. Neuroreport. 6:1995;2314-2316.
182. *Morgan, M.M.; Whitney, P.K.; Boyer, J.S.; Strack, A.M., Chemical stimulation of the rostral ventromedial medulla: analysis of conditioned place avoidance and stress hormone release. Soc. Neurosci. 22:113, Abstr; 1996.
183. *Moroz, I.; Parker, L.A.; Siegel, S., Ibogaine interferes with the establishment of amphetamine place preference learning. Soc. Neurosci., 22:707, Abstr; 1996.
184. Nader K., Bechara A., van der Kooy D. Lesions of the lateral parabrachial nucleus block the aversive motivational effects of both morphine and morphine withdrawal but spare morphine's discriminative properties. Behav. Neurosci. 110:1996;1496-1502.
185. *Nader, K.; van der Kooy, D., The motivation produced by food and morphine are isomorphic: approaches to specific motivational stimuli are learned. Soc. Neurosci. 18:875, Abstr; 1992.
186. Nader K., van der Kooy D. The motivation produced by morphine and food are isomorphic: approaches to specific motivational stimuli are learned. Psychobiol. 22:1994;68-76.
187. *Nader, K.; van der Kooy, D., Clonidine antagonizes the rewarding effects of morphine only in opiate withdrawn rats as well as the aversive effects of opiate withdrawal itself. Soc. Neurosci. 20:1233, Abstr; 1994.
188. •Navarro, M.; Rubio, P.; de Fonseca, F.R., Behavioural consequences of maternal exposure to natural cannabinoids in rats. Psychopharmacology 122:1-14; 1995.
189. Noble F.et al. Unlike morphine the endogenous enkephalins protected by RB101 are unable to establish a conditioned place preference in mice. Eur. J. Pharmacol. 230:1993;139-149.
190. *Nocent, D.P.; Mallet, P.E.; Beninger, R.J., Systemic but not intra-accumbens injection of 7-OH-DPAT produce a place preference in rats. Soc. Neurosci. 22:1128, Abstr; 1996.
191. *Nocjar, C.; Tavernetti, M.; Middaugh, L.D., Ethanol place-preference conditioning in C57BL/6 mice: a preliminary study. Soc. Neurosci. 22:699, Abstr; 1996.
192. Oberling P., Rocha B., Di Scala G., Sandner G. Evidence for state-dependent retrieval in conditioned place aversion. Behav. Neural Biol. 60:1993;27-32.
193. O'Dell L. E., Khroyan T. V., Neisewander J. L. Dose-dependent characterization of the rewarding and stimulant properties of cocaine following intraperitoneal and intravenous administration in rats. Psychopharmacology. 123:1996;144-153.
194. *O'Dell, L.E.; Sussman, A.N.; Meyer, K.L.; Neisewander, J.L., Stimulant and rewarding properties of cocaine following intra-ventricular or intra-amygdala infusions. Soc. Neurosci. 22:927, Abstr; 1996.
195. Oldenburger W. P., Everitt B. J., de Jonge F. H. Conditioned place preference induced by sexual interaction in female rats. Horm. Behav. 26:1992;214-228.
196. *Olmstead, M.C.; Franklin, K.B.J., Differential effects of nucleus accumbens lesions on the conditioned place preference induced by morphine or amphetamine. Soc. Neurosci. 18:1574, Abstr; 1992.
197. Olmstead M. C., Franklin K. B. J. Effects of pedunculopontine tegmental nucleus lesions on morphine-induced conditioned place preference and analgesia in the formalin test. Neuroscience. 57:1993;411-418.
198. *Olmstead, M.C.; Franklin, K.B.J., The development of a conditioned place preference (CPP) to morphine. 1. Effects of lesions of various CNS sites. Soc. Neurosci. 20:1230, Abstr; 1994.
199. Olmstead M. C., Franklin K. B. J. Lesions of the pedunculopontine tegmental nucleus block drug-induced reinforcement but not amphetamine-induced locomotion. Brain Res. 638:1994;29-35.
200. Olmstead M. C., Franklin K. B. Differential effects of ventral striatal lesions on the conditioned place preference induced by morphine or amphetamine. Neuroscience. 71:1996;701-708.
201. Pain L., Oberling P., Sandner G., Di Scala G. Effect of propofol on affective state as assessed by place conditioning paradigm in rats. Anesthesiology. 85:1996;121-128.
202. Papp M., Lappas S., Muscat R., Wiliner P. Attenuation of place preference conditioning but not place aversion conditioning by chronic mild stress. J. Psychopharmacol. 6:1992;352-356.
203. Papp M., Moryl E. Rewarding properties of non-competitive and competitive NMDA antagonists as measured by place preference conditioning in rats. Pol. J. Pharmacol. 46:1994;79-81.
204. Papp M., Moryl E., Maccecchini M. L. Differential effects of agents acting at various sites of the NMDA receptor complex in a place preference conditioning model. Eur. J. Pharmacol. 317:1996;191-196.
205. Papp M., Muscat R., Willner P. Subsensitivity to rewarding and locomotor stimulant effects of a dopamine agonist following chronic mild stress. Psychopharmacology. 110:1993;152-158.
206. Papp M., Willner P., Muscat R. Behavioral sensitization to a dopamine agonist is associated with reversal of stress-induced anhedonia. Psychopharmacology. 110:1993;159-164.
207. *Paredes, R.G.; Romero, V.; Agmo, A., Induction of conditioned place preference by electrical kindling. Soc. Neurosci. 18:658, Abstr; 1992.
208. Parker L. A. Place conditioning in a three- or four-choice apparatus: role of stimulus novelty in drug-induced place conditioning. Behav. Neurosci. 106:1992;294-306.
209. Parker L. A. LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats. Behav. Neurosci. 110:1996;503-508.
210. *Parker, L.A., Erb, S.; Horn, D., Individual differences in amphetamine induced place conditioning. Soc. Neurosci. 19:823, Abstr; 1993.
211. Parker L. A., Gillies T. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats. Behav. Neurosci. 109:1995;71-78.
212. Parker L. A., Rennie M. Naltrexone-induced aversions: assessment by place conditioning, taste reactivity and taste avoidance paradigms. Pharmacol. Biochem. Behav. 41:1992;559-565.
213. Parker L. A., Tomlinson T., Horn D., Erb S. Relative strength of place conditioning produced by cocaine and morphine assessed in a three-choice paradigm. Learn. Motiv. 25:1994;83-94.
214. *Parker, L.A.; van der Kooy, D., The aversiveness of cocaine withdrawal is revealed in a place conditioning paradigm. Soc. Neurosci. 18:1571, Abstr; 1992.
215. Parker J. L., van der Kooy D. Tegmental pedunculopontine nucleus lesions do not block cocaine reward. Pharmacol. Biochem. Behav. 52:1995;77-83.
216. *Philpot, R.M.; Dark, T.; Guion, E.; Kirstein, C.L., Early olfactory learning: Cocaine-induced odor preference. Soc. Neurosci. 22:1887, Abstr; 1996.
217. Pierce R. C., Rowlett J. K., Rebec G. V., Bardo M. T. Ascorbate potentiates amphetamine-induced conditioned place preference and forebrain dopamine release in rats. Brain Res. 688:1995;21-26.
218. *Pina, A.L.; Ormsby, C.E.; Ramirez-Amaya, V.; Bermudez-Rattoni, F., Differential effects of insular cortex and dorsal striatum lesions in a place conditioning task. Soc. Neurosci. 19:1229, Abstr; 1993.
219. *Pomerantz, S.M.; Wertz, I.; Hepner, B.; Wasio, L.; Piazza, I., Cocaine-induced conditioned place preference in rhesus monkeys. Soc. Neurosci. 18:1572, Abstr; 1992.
220. *Pratt, J.A.; Gray, A., Involvement of AMPA/kinate receptors in diazepam induced conditioned place preference in rats. Soc. Neurosci. 22:2075, Abstr; 1996.
221. Pruitt D. L., Bolanos C. A., McDougall S. A. Effects of dopamine D1 and D2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats. Eur. J. Pharmacol. 283:1995;125-131.
222. Pucilowski O., Garges P. L., Rezvani A. H., Hutheson S., Janowsky D. S. Verapamil suppresses d-amphetamine-induced place preference conditioning. Eur. J. Pharmacol. 240:1993;89-92.
223. Pucilowski O., Plaznik A., Overstreet D. H. lsradipine suppresses amphetamine-induced conditioned place preference and locomotor stimulation in the rat. Neuropsychopharmacology. 12:1995;239-244.
224. Reid L. D., Hubbell C. L. An assessment of the addiction potential of the opioid associated with milk. J. Dairy Sci. 77:1994;672-675.
225. Reilly S., Grigson P. S., Norgren R. Parabrachial nucleus lesions and conditioned taste aversion: evidence supporting an associative deficit. Behav. Neurosci. 107:1993;1005-1017.
226. Richardson N. R., Piercey M. F., Svensson K., Collins R. J., Myers J. E., Roberts D. C. Antagonism of cocaine self-administration by the preferential dopamine autoreceptor antagonist (+)-AJ 76. Brain Res. 619:1993;15-21.
227. Rigon A. R., Takahashi R. N. Stimulant activities of dimethocaine in mice: reinforcing and anxiogenic effects. Psychopharmacology. 127:1996;323-327.
228. Risinger F. O., Bormann N. M., Oakes R. A. Reduced sensitivity to ethanol reward, but not ethanol aversion, in mice lacking 5-HT1B receptors. Alc. Clin. Exp. Res. 20:1996;1401-1405.
229. Risinger F. O., Cunningham C. L. Ethanol produces rapid biphasic hedonic effects. Ann. NY Acad. Sci. 654:1992;506-508.
230. Risinger F. O., Dickinson S. D., Cunningham C. L. Haloperidol reduces ethanol-induced motor activity stimulation but not conditioned place preference. Psychopharmacology. 107:1992;453-456.
231. Risinger F. O., Malott D. H., Prather L. K., Niehus D. R., Cunningham C. L. Motivational properties of ethanol in mice selectively bred for ethanol-induced locomotor differences. Psychopharmacology. 116:1994;207-216.
232. Risinger F. O., Malott D. H., Riley A. L., Cunningham C. L. Effect of Ro 15-4513 on ethanol-induced conditioned place preference. Pharmacol. Biochem. Behav. 43:1992;97-102.
233. Risinger F. O., Oakes R. A. Nicotine-induced conditioned place preference and conditioned place aversion in mice. Pharmacol. Biochem. Behav. 51:1995;457-461.
234. Risinger F. O., Oakes R. A. Dose- and conditioning trial-dependent ethanol-induced conditioned place preference in Swiss-Webster mice. Pharmacol. Biochem. Behav. 55:1996;117-123.
235. 1C receptor antagonists. Behav. Pharmacol. 4:1993;101-106.
236. Rocha B., Di Scala G., Rigo M., Hoyer D., Sandner G. Effect of 5,7 dihydroxytryptamine lesion on mianserin-induced conditioned place aversion and on 5-hydroxytryptamine lC receptors in the rat brain. Neuroscience. 56:1993;687-693.
237. Rowlett J. K., Gibson T. R., Bardo M. T. Dissociation of buprenorphin-induced locomotor sensitization and conditioned place preference in rats. Pharmacol. Biochem. Behav. 49:1994;241-245.
238. *Rowlett, J.K.; Gibson, T.R.; Valone, J.M.; Bardo, M.T., Conditioned place preference with buprenorphine: interactions with naltrexone, morphine and amphetamine. Soc. Neurosci. 19:1026, Abstr; 1993.
239. Sala M., Braida D., Calcaterra P., Leone M. P., Gori E. Dose-dependent conditioned place preference produced by etonitazene and morphine. Eur. J. Pharmacol. 217:1992;37-41.
240. Sala M., Braida D., Colombo M., Groppetti A., Sacco S., Gori E., Parenti M. Behavioral and biochemical evidence of opioidergic involement in cocaine sensitization. J. Pharmacol. Exp. Ther. 274:1995;450-457.
241. Schalomon P. M., Robertson A. M., Laferriere A. Prefrontal cortex and the relative associability of taste and place cues in rats. Behav. Brain Res. 65:1994;57-65.
242. Schechter M. D. Locomotor activity but not conditioned place preference is differentially affected by a moderate does of ethanol administered to P and NP rats. Alcohol. 9:1992;185-188.
243. Schechter M. D. Rats bred for differences in preference to cocaine: other behavioral measurements. Pharmacol. Biochem. Behav. 43:1992;1015-1021.
244. Schechter M. D. Cocaethylene produces conditioned place preference in rats. Pharmacol. Biochem. Behav. 51:1995;549-552.
245. •Schechter, M.D.; Calcagnetti, D.J., Trends in place preference conditioning with a cross-indexed bibliography, 1957-1991. Neurosci. Biobehav. Rev. 17:21-41; 1993.
246. Schechter M. D., Krimmer E. C. Differences in response to the aversive properties and activity effects of low dose ethanol in LAS and HAS selectively bred rats. Psychopharmacology. 107:1992;564-568.
247. Schechter M. D., Meehan S. M. Conditioned place preference produced by the psychostimulant cathinone. Eur. J. Pharmacol. 232:1993;135-138.
248. Schechter M. D., Meehan S. M. Conditioned place aversion produced by dopamine release inhibition. Eur. J. Pharmacol. 260:1994;133-137.
249. Schechter M. D., Meehan S. M., Schechter J. B. Genetic selection for nicotine activity in mice correlates with conditioned place preference. Eur. J. Pharmacol. 279:1995;59-64.
250. Schmid A., Koch M., Schnitzler H.-U. Conditioned pleasure attenuates startle response in rats. Neurobiol. Learn. Mem. 64:1995;1-3.
251. Schnur P., Wainwright M. Conditioned withdrawal in environments associated with the presence or absence of morphine. Pharmacol. Biochem. Behav. 41:1992;543-546.
252. Self D. W., Stein L. Receptor subtypes in opioid and stimulant reward. Pharmacol. Toxicol. 70:1992;87-94.
253. Seidman M. H., Lau C. E., Chen R., Falk J. L. Orally self-administered cocaine: reinforcing efficacy by the place preference method. Pharmacol. Biochem. Behav. 43:1992;235-241.
254. Semenova S., Kuzmin A., Zvartau E. Strain differences in the analgesic and reinforcing action of morphine in mice. Pharmacol. Biochem. Behav. 50:1995;17-21.
255. Shippenberg T. S., Bals-Kubik R., Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors. J. Pharmacol. Exp. Ther. 265:1993;53-59.
256. Shippenberg T. S., Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur. J. Pharmacol. 280:1995;55-61.
257. Shippenberg T. S., Herz A., Spangel R., Bals-Kubik R., Stein C. Conditioning of opioid reinforcement: neuroanatomical and neurochemical substrates. Ann. NY Acad. Sci. 654:1992;347-356.
258. Shippenberg T. S.et al. Kappa-opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine. J. Pharmacol. Exp. Ther. 276:1996;545-554.
259. Shoaib, M.; Stolerman, I.P., Contrasting motivational properties of nicotine detected with a place conditioning paradigm. In: Harris, L., ed., Problems of Drug Dependence, 1992, Vol. 132, NIDA Res. Monograph. Rockville, MD: NIDA; 1993:244.
260. Shoaib M., Stolerman I. P., Kumar R. C. Nicotine-induced place preference following prior nicotine exposure in rats. Psychopharmacology. 113:1994;445-452.
261. Singh L., Field M. J., Hunter J. C., Oles R. J., Woodruff G. N. Modulation of the in vivo actions of morphine by the mixed CCKA/B receptor antagonist PD 142898. Eur. J. Pharmacol. 307:1996;283-289.
262. Singh L., Oles R. J., Field M. J., Atwal P., Woodruff G. N., Hunter J. C. Effect of CCK receptor antagonists on the antinociceptive, reinforcing and gut motility properties of morphine. Br. J. Pharmacol. 118:1996;1317-1325.
263. Sprick U., Hasenohrl R. U., Krauth J., Klapdor K., Huston J. P. Effects of chronic substance P treatment and intracranial fetal grafts on learning after hippocampal kainic acid lesions. Peptides. 17:1996;275-285.
264. Stefurak T. L., van der Kooy D. Saccharin's rewarding, conditioned reinforcing, and memory-improving properties: mediation by isomorphic or independent processes? Behav. Neurosci. 106:1992;125-139.
265. Stefurak T. L., van der Kooy D. Tegmental pedunculopontine lesions in rats decrease saccharin's rewarding effects but not its memory-improving effect. Behav. Neurosci. 108:1994;972-980.
266. Steinpreis R. E., Kramer M. A., Mix K. S., Piwowarczyk M. C. The effects of MK-801 on place conditioning. Neurosci. Res. 22:1995;427-430.
267. Steinpreis R. E., Rutell A. L., Parrett F. A. Methadone produces conditioned place preference in the rat. Pharmacol. Biochem. Behav. 54:1996;339-341.
268. Stewart R. B., Murphy J. M., McBride W. J., Lumeng L., Li T.-K. Place conditioning with alcohol in alcohol-preferring and -nonpreferring rats. Pharmacol. Biochem. Behav. 53:1996;487-491.
269. Stinus L., Cador M., Le Moal M. Interaction between endogenous opioids and dopamine within the nucleus accumbens. Ann. NY Acad. Sci. 654:1992;254-273.
270. *Sufka, K.J., Dose-dependent diminished sensitivity to morphine place preference in rats with persistent inflammatory pain. Soc. Neurosci. 19:1796, Abstr; 1993.
271. Sufka K. J. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Pain. 58:1994;355-366.
272. *Suzuki, T.; Bi, Y.; Misawa, M.; Meisch, R.A., Studies on drug dependence (Rept. 227): reinforcing properties of morphine and etonitazene by conditioned place preference in two inbred strains of rats. Jpn. J. Pharmacol 61:300P; 1993.
273. Suzuki T., Funada M., Narita M., Misawa M., Nagase H. Morphine-induced place preference in the CXBK mouse: characteristics of opioid receptor subtypes. Brain Res. 602:1993;45-52.
274. Suzuki T., Funada M., Sugano Y., Misawa M., Okutomi T., Soma G.-I., Mizuno D. Effects of a lipolysaccharide from Pantoea Agglomerans on the cocaine-induced conditioned place preference. Life Sci. Pharmacol. Lett. 54:1994;PL75-PL80.
275. Suzuki T., Ise Y., Tsuda M., Maeda J., Misawa M. Mecamylamine-precipitated nicotine-withdrawal aversion in rats. Eur. J. Pharmacol. 314:1996;281-284.
276. Suzuki T., Kishimoto Y., Misawa M. Formalin- and carrageenan-induced inflammation attenuates place preferences produced by morphine, methamphetamine and cocaine. Life Sci. 59:1996;1667-1674.
277. Suzuki T., Misawa M. Sertindole antagonizes morphine-, cocaine-, and methamphetamine-induced place preference in the rat. Life Sci. 57:1995;1277-1284.
278. Suzuki T., Mori T., Tsuji M., Misawa M., Nagase H. The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences. Life Sci. 55:1994;PL339-PL344.
279. Suzuki T., Shiozaki Y., Masukawa Y., Misawa M. Effects of calcium antagonists on the cocaine- and methamphetamine-induced conditioned place preference. Jpn. J. Alcohol Studies Drug Dep. 27:1992;81-90.
280. Suzuki T., Shiozaki Y., Masukawa Y., Misawa M., Nagase H. The role of mu- and kappa-opioid receptors in cocaine-induced conditioned place preference. Jpn. J. Pharmacol. 58:1992;435-442.
281. *Suzuki, T.; Shiozaki, Y.; Moriizumi, T.; Misawa, M., Studies on drug dependence (Rept. 211): establishment of ethanol-induced conditioned place preference in rats. Jpn. J. Psychopharmacol. 58:411P; 1992.
282. Suzuki T., Shiozaki Y., Moriizumi T., Misawa M. 5-HT3 receptor antagonists block cocaine- and methamphetamine-induced place preference. Jpn. J. Psychopharmacol. 12:1992;33-38.
283. Suzuki T., Shiozaki Y., Moriizumi T., Misawa M. Establishment of ethanol-induced conditioned place preference in rats. Jpn. J. Alcohol Studies Drug Dep. 27:1992;111-123.
284. Suzuki T., Sugano Y., Funada M., Misawa M. Adrenalectomy potentiates the morphine- but not cocaine-induced place preference in rats. Life Sci. 56:1995;PL339-344.
285. Suzuki T., Takamori K., Misawa M., Onodera K. Effects of the histaminergic system on the morphine-induced conditioned place preference in mice. Brain Res. 675:1995;195-202.
286. Suzuki T., Yoshhiike M., Mozoguchi H., Kamei M., Misawa M., Nagase H. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmacol. 66:1994;131-137.
287. *Tanaka, C.; Endo, T.; Nagase, H., Role of kappa and sigma receptors in U50488H-induced conditioned place aversion in rats. Jpn. J. Pharmacol. 61:181P; 1993.
288. *Thomas, D.N.; Fontana, D.J.; Post, R.M.; Weiss, S.R.B.; Pert, A., The involvement of the Mesocorticolimbic dopamine system in the conditioned effects of cocaine. In: Harris, L., ed., Problems of Drug Dependence, 1992, Vol. 132, NIDA Res. Monograph. Rockville, MD: NIDA; 1993:260.
289. *Thompson, K.; Panos, J.J.; Egan, T.E.; Kramer, M.; Steinpreis, R.E., Assessing the appetitive properties of glutamatergic compounds using the conditioned place preference paradigm. Soc. Neurosci., 22:2131, Abstr; 1996.
290. *Thompson, A.C.; Shippenberg, T.S., Delta-opioid receptor blockade prevents sensitization to the conditioned reinforcing effects of morphine. Soc. Neurosci. 22:172, Abstr; 1996.
291. Tokuyama S., Nakamura F., Nakao K., Takahashi M., Kaneto H. A potent mu-opioid receptor agonist, dihydroetorphine, fails to produce conditioned place preference in mice. Jpn. J. Pharmacol. 71:1996;357-360.
292. Tokuyama S., Takahashi M., Kaneto H. Effect of ginseng extract on development of reversing tolerance and conditioned place preference to methamphetamine and cocaine in mice. Jpn. J. Pharmacol. 61:1993;143P.
293. Tokuyama S., Takahashi M., Kaneto H. The effect of ginseng extract on locomotor sensitization and conditioned place preference induced by methamphetamine and cocaine in mice. Pharmacol. Biochem. Behav. 54:1996;671-676.
294. Tsuji M., Nakagawa Y., lshibashi Y., Yoshii T., Takashima T., Shimada M., Suzuki T. Activation of ventral tegmental GABAb receptors inhibits morphine-induced place preference in rats. Eur. J. Pharmacol. 313:1996;169-173.
295. Tsybulsky V. L., Belyi M. V., Surkova L. A., Belyi V. P. Study of the role of visual stimuli in conditioning of place preference with morphine reinforcement. Zh Vyssh. Nerv. Deiat. Im. I.P. Pavlova. 42:1992;679-686.
296. Tuazon D. B., Suzuki T., Misawa M., Watanabe S. Methylxanthines (caffeine and theophilline) blocked methamphetamine-induced conditioned place preference in mice but enhanced that induced by cocaine. Ann. NY Acad. Sci. 654:1992;531-533.
297. Turenne S. D., Miles C., Parker L. A., Siegel S. Individual differences in reactivity to the rewarding/aversive properties of drugs: assessment by taste and place conditioning. Pharmacol. Biochem. Behav. 53:1996;511-516.
298. Tzschentke T. M., Schmidt W. J. N-methyl-D-aspartic acid-receptor antagonists block morphine-induced conditioned place preference in rats. Neurosci. Lett. 193:1995;37-40.
299. Vaccarino A. L., Plamondon H., Melzack R. Analgesic and aversive effects of naloxone in BALB/c mice. Exper. Neurol. 117:1992;216-218.
300. *Valone, J.M.; Gibson, T.B.; Bevins, R.A.; Bardo, M.J., Intravenous amphetamine produces conditioned place preference using a single trial in rats. Soc. Neurosci. 20:1029, Abstr; 1994.
301. Valverde O., Fournie-Zaluski M. C., Roques B. P., Maldonado R. The CCKB antagonist PD-134, 308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology. 123:1996;119-126.
302. *Wang, S.; Barr, G.A., Gender differences in place preference induced by ICV injections of cocaine. Soc. Neurosci. 18, 545, Abstr; 1992.
303. White N. M., Hiroi N. Pipradol conditioned place preference is blocked by SCH 23390. Pharmacol. Biochem. Behav. 43:1992;377-380.
304. *White, N.M.; McDonald, R.J., Amygdala-hippocampus interactions of the conditioned cue preference (CCP) memory task. Soc. Neurosci. 19:363, Abstr; 1993.
305. White N. M., McDonald R. J. Acquisition of a spatial conditioned place preference is impaired by amygdala lesions and improved by fornix lesions. Behav. Brain Res. 55:1993;269-281.
306. *Will, M.J.; Watkins, L.R.; Maier, S.F., Nature of stress induced potentiation of morphine's rewarding properties. Soc. Neurosci. 22:172, Abstr; 1996.
307. •Witt, E.D., Mechanisms of alcohol abuse and alcoholism in adolescents: a case for developing animal models. Behav. Neural. Biol. 62:168-177; 1994.
308. Wongwitdecha N., Marsden C. A. Isolation rearing prevents the reinforcing properties of amphetamine in a conditioned place preference paradigm. Eur. J. Pharm. 279:1995;99-103.
309. Wongwitdecha N., Marsden C. A. Effect of social isolation on the reinforcing properties of morphine in the conditioned place preference test. Pharmacol. Biochem. Behav. 53:1996;531-534.
310. Yavich L., Patkina N., Zvartau E. Experimental estimation of addictive potential of a mixture of organic solvents. Eur. Neuropsychopharmacol. 4:1994;111-118.
311. *Zaratin, P.; Petrone, G.; Pizzi, A.; Sbacchi, M.; Clarke, G.D., The antinociceptive and behavioral properties of BRL 53001A: a new kappa opioid agonist. Pharmacol. Res. 25:269-270; 1992.
312. Zvartau E. E. The psychopharmacology of narcotics: a pre-clinical study. Eksp. Klin. Farmakol. 55:1992;65-68.